taxifolin and 2019 Novel Coronavirus Disease

taxifolin has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ananyan, MA; Belosludtseva, NV; Mironova, GD1

Other Studies

1 other study(ies) available for taxifolin and 2019 Novel Coronavirus Disease

ArticleYear
Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:16

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Erythrocytes; Free Radical Scavengers; Hemoglobins; Humans; Oxidative Stress; Pandemics; Pneumonia, Viral; Pulmonary Alveoli; Quercetin; Reactive Oxygen Species; SARS-CoV-2; Uridine

2020